Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Cyclically Adjusted Book per Share: ¥10.23 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600566 Hubei Jumpcan Pharmaceutical Co Ltd SHSE:600566
84 GF Score
Price ¥26.92
GF Value ¥21.00
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Hubei Jumpcan Pharmaceutical Co Cyclically Adjusted Book per Share?

Hubei Jumpcan Pharmaceutical Co SHSE:600566 +2.55% 84 Cyclically Adjusted Book per Share is ¥10.23 as of Mar. 2026. GuruFocus rates SHSE:600566 with a GF Score™ of 84/100 and a GF Value™ of ¥21.00 (Modestly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Hubei Jumpcan Pharmaceutical Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥16.263. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥10.23 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Hubei Jumpcan Pharmaceutical Co's average Cyclically Adjusted Book Growth Rate was 14.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 16.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 14.70% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 10.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Hubei Jumpcan Pharmaceutical Co was 16.00% per year. The lowest was -2.80% per year. And the median was 6.30% per year.

As of today (2026-07-19), Hubei Jumpcan Pharmaceutical Co's current stock price is ¥26.92. Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥10.23. Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is 2.63.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hubei Jumpcan Pharmaceutical Co was 13.28. The lowest was 2.20. And the median was 4.58.


Hubei Jumpcan Pharmaceutical Co  (SHSE:600566) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=26.92/10.23
=2.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hubei Jumpcan Pharmaceutical Co was 13.28. The lowest was 2.20. And the median was 4.58.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Hubei Jumpcan Pharmaceutical Co Cyclically Adjusted Book per Share Related Terms


Hubei Jumpcan Pharmaceutical Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hubei Jumpcan Pharmaceutical Co Cyclically Adjusted Book per Share Chart

Hubei Jumpcan Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.61 6.33 7.39 8.61 9.88

Hubei Jumpcan Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.96 9.22 9.55 9.88 10.23

SHSE:600566 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hubei Jumpcan Pharmaceutical Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted PB Ratio falls into.


SHSE:600566
84GF Score
Hubei Jumpcan Pharmaceutical Co Ltd SHSE:600566
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hubei Jumpcan Pharmaceutical Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hubei Jumpcan Pharmaceutical Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=16.263/116.3033*116.3033
=16.263

Current CPI (Mar. 2026) = 116.3033.

Hubei Jumpcan Pharmaceutical Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.907 101.400 4.481
201609 4.198 102.400 4.768
201612 4.517 102.600 5.120
201703 4.815 103.200 5.426
201706 4.445 103.100 5.014
201709 4.847 104.100 5.415
201712 5.437 104.500 6.051
201803 6.013 105.300 6.641
201806 5.643 104.900 6.256
201809 6.233 106.600 6.800
201812 6.725 106.500 7.344
201903 7.328 107.700 7.913
201906 6.700 107.700 7.235
201909 7.119 109.800 7.541
201912 7.491 111.200 7.835
202003 8.060 112.300 8.347
202006 7.101 110.400 7.481
202009 9.136 111.700 9.513
202012 8.740 111.500 9.117
202103 9.234 112.662 9.532
202106 9.251 111.769 9.626
202109 9.760 112.215 10.116
202112 10.264 113.108 10.554
202203 10.918 114.335 11.106
202206 10.727 114.558 10.890
202209 11.300 115.339 11.395
202212 12.299 115.116 12.426
202303 13.028 115.116 13.162
202306 12.877 114.558 13.073
202309 13.520 115.339 13.633
202312 14.482 114.781 14.674
202403 15.399 115.227 15.543
202406 14.654 114.781 14.848
202409 15.267 115.785 15.335
202412 15.951 114.893 16.147
202503 16.428 115.116 16.597
202506 14.651 114.907 14.829
202509 15.021 115.471 15.129
202512 15.852 115.832 15.916
202603 16.263 116.303 16.263

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥10.23 mean?
Hubei Jumpcan Pharmaceutical Co (SHSE:600566) has a Cyclically Adjusted Book per Share of ¥10.23 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors.
Is Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted Book per Share too high?
Hubei Jumpcan Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥10.23. Overall, Hubei Jumpcan Pharmaceutical Co has a GF Score™ of 84/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Hubei Jumpcan Pharmaceutical Co's Cyclically Adjusted Book per Share of ¥10.23 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Hubei Jumpcan Pharmaceutical Co and its competitors. Hubei Jumpcan Pharmaceutical Co's current Cyclically Adjusted Book per Share is ¥10.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hubei Jumpcan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co (SHSE:600566) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥21.00, compared to a current price of ¥26.92 — trading 28.2% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥10.23. Hubei Jumpcan Pharmaceutical Co's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Hubei Jumpcan Pharmaceutical Co (SHSE:600566), the current Cyclically Adjusted Book per Share is ¥10.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hubei Jumpcan Pharmaceutical Co (SHSE:600566) Overvalued in 2026?

Based on GuruFocus' analysis, Hubei Jumpcan Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥26.92 is trading 28.2% above its estimated GF Value™ of ¥21.00. GuruFocus considers Hubei Jumpcan Pharmaceutical Co to be Modestly Overvalued.

Key valuation signals for SHSE:600566:

  • Cyclically Adjusted Book per Share: ¥10.23
  • GF Value™: ¥21.00 vs. price of ¥26.92 (28.2% above fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hubei Jumpcan Pharmaceutical Co Business Description

Address Daqing West Road, Baota Bay, Jiangsu Province, Taixing, CHN, 225441
Hubei Jumpcan Pharmaceutical Co Ltd engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemicals based on Chinese traditional medicines, and Chinese medicine health products in China. It offers Chinese and Western medicines in the areas of pediatrics, gynecology, pneumonology, gastroenterology, and geriatrics. The company also develops Chinese and Western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
84GF Score

Get the complete analysis for SHSE:600566

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥26.92
Price
¥21.00
GF Value